157 related articles for article (PubMed ID: 8218098)
1. Effect of 3-thiadicarboxylic acid on lipid metabolism in experimental nephrosis.
al-Shurbaji A; Skorve J; Berge RK; Rudling M; Björkhem I; Berglund L
Arterioscler Thromb; 1993 Nov; 13(11):1580-6. PubMed ID: 8218098
[TBL] [Abstract][Full Text] [Related]
2. On the mechanism of the hypolipidemic effect of sulfur-substituted hexadecanedioic acid (3-thiadicarboxylic acid) in normolipidemic rats.
Skorve J; al-Shurbaji A; Asiedu D; Björkhem I; Berglund L; Berge RK
J Lipid Res; 1993 Jul; 34(7):1177-85. PubMed ID: 8371065
[TBL] [Abstract][Full Text] [Related]
3. Hepatic fatty acid metabolism as a determinant of plasma and liver triacylglycerol levels. Studies on tetradecylthioacetic and tetradecylthiopropionic acids.
Asiedu DK; al-Shurbaji A; Rustan AC; Björkhem I; Berglund L; Berge RK
Eur J Biochem; 1995 Feb; 227(3):715-22. PubMed ID: 7867630
[TBL] [Abstract][Full Text] [Related]
4. The hypocholesterolemic effect of sulfur-substituted fatty acid analogues in rats fed a high carbohydrate diet.
Skorve J; Berge RK
Biochim Biophys Acta; 1993 Apr; 1167(2):175-81. PubMed ID: 8466946
[TBL] [Abstract][Full Text] [Related]
5. Effect of pravastatin sodium, a new inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase, on very-low-density lipoprotein composition and kinetics in hyperlipidemia associated with experimental nephrosis.
Hirano T; Komuro F; Furukawa S; Nagano S; Takahashi T
Metabolism; 1990 Jun; 39(6):605-9. PubMed ID: 2112675
[TBL] [Abstract][Full Text] [Related]
6. On the interrelationship between hepatic carnitine, fatty acid oxidation, and triglyceride biosynthesis in nephrosis.
al-Shurbaji A; Berglund L; Berge RK; Cederblad G; Humble E
Lipids; 1997 Aug; 32(8):847-52. PubMed ID: 9270976
[TBL] [Abstract][Full Text] [Related]
7. Fluvastatin, a new inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase, suppresses very low-density lipoprotein secretion in puromycin aminonucleoside-nephrotic rats.
Moritomo Y; Hirano T; Ebara T; Kurokawa M; Naito H; Furukawa S; Nagano S
Nephron; 1994; 67(2):218-25. PubMed ID: 8072613
[TBL] [Abstract][Full Text] [Related]
8. Alkylthioacetic acids (3-thia fatty acids) as non-beta-oxidizable fatty acid analogues: a new group of hypolipidemic drugs. III. Dissociation of cholesterol- and triglyceride-lowering effects and the induction of peroxisomal beta-oxidation.
Aarsland A; Aarsaether N; Bremer J; Berge RK
J Lipid Res; 1989 Nov; 30(11):1711-8. PubMed ID: 2614273
[TBL] [Abstract][Full Text] [Related]
9. Regulation of fatty acid oxidation and triglyceride and phospholipid metabolism by hypolipidemic sulfur-substituted fatty acid analogues.
Skorve J; Asiedu D; Rustan AC; Drevon CA; al-Shurbaji A; Berge RK
J Lipid Res; 1990 Sep; 31(9):1627-35. PubMed ID: 2174075
[TBL] [Abstract][Full Text] [Related]
10. Lipoproteins in experimental nephrosis: plasma levels and composition.
Marsh JB; Sparks CE
Metabolism; 1979 Oct; 28(10):1040-5. PubMed ID: 226831
[TBL] [Abstract][Full Text] [Related]
11. Catabolism of very low density lipoproteins in experimental nephrosis.
Garber DW; Gottlieb BA; Marsh JB; Sparks CE
J Clin Invest; 1984 Oct; 74(4):1375-83. PubMed ID: 6480830
[TBL] [Abstract][Full Text] [Related]
12. The role of ATP citrate-lyase in the metabolic regulation of plasma lipids. Hypolipidaemic effects of SB-204990, a lactone prodrug of the potent ATP citrate-lyase inhibitor SB-201076.
Pearce NJ; Yates JW; Berkhout TA; Jackson B; Tew D; Boyd H; Camilleri P; Sweeney P; Gribble AD; Shaw A; Groot PH
Biochem J; 1998 Aug; 334 ( Pt 1)(Pt 1):113-9. PubMed ID: 9693110
[TBL] [Abstract][Full Text] [Related]
13. Protective effect of rutin on lipids, lipoproteins, lipid metabolizing enzymes and glycoproteins in streptozotocin-induced diabetic rats.
Stanely Mainzen Prince P; Kannan NK
J Pharm Pharmacol; 2006 Oct; 58(10):1373-83. PubMed ID: 17034661
[TBL] [Abstract][Full Text] [Related]
14. Acute modulation of rat hepatic lipid metabolism by sulphur-substituted fatty acid analogues.
Asiedu DK; Demoz A; Skorve J; Grav HJ; Berge RK
Biochem Pharmacol; 1995 Mar; 49(7):1013-22. PubMed ID: 7741757
[TBL] [Abstract][Full Text] [Related]
15. Long-term effect of tetradecylthioacetic acid: a study on plasma lipid profile and fatty acid composition and oxidation in different rat organs.
Asiedu DK; Frøyland L; Vaagenes H; Lie O; Demoz A; Berge RK
Biochim Biophys Acta; 1996 Apr; 1300(2):86-96. PubMed ID: 8652642
[TBL] [Abstract][Full Text] [Related]
16. The magnitude of decrease in hepatic very low density lipoprotein apolipoprotein B secretion is determined by the extent of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibition in miniature pigs.
Burnett JR; Wilcox LJ; Telford DE; Kleinstiver SJ; Barrett PH; Newton RS; Huff MW
Endocrinology; 1999 Nov; 140(11):5293-302. PubMed ID: 10537160
[TBL] [Abstract][Full Text] [Related]
17. Hyperlipoproteinemia of aminonucleoside-induced nephrotic syndrome--modulation by glucocorticoids and triiodothyronine.
Shafrir E
Isr J Med Sci; 1996 Jun; 32(6):390-7. PubMed ID: 8682644
[TBL] [Abstract][Full Text] [Related]
18. Enhancement of fatty acid and cholesterol synthesis accompanied by enhanced biliary but not very-low-density lipoprotein lipid secretion following sustained pravastatin blockade of hydroxymethyl glutaryl coenzyme A reductase in rat liver.
Carrella M; Fong LG; Loguercio C; Del Piano C
Metabolism; 1999 May; 48(5):618-26. PubMed ID: 10337863
[TBL] [Abstract][Full Text] [Related]
19. Acyl-coenzyme A:cholesterol acyltransferase inhibition ameliorates proteinuria, hyperlipidemia, lecithin-cholesterol acyltransferase, SRB-1, and low-denisty lipoprotein receptor deficiencies in nephrotic syndrome.
Vaziri ND; Liang KH
Circulation; 2004 Jul; 110(4):419-25. PubMed ID: 15262831
[TBL] [Abstract][Full Text] [Related]
20. Effect of cyclosporine on HMG-CoA reductase, cholesterol 7alpha-hydroxylase, LDL receptor, HDL receptor, VLDL receptor, and lipoprotein lipase expressions.
Vaziri ND; Liang K; Azad H
J Pharmacol Exp Ther; 2000 Aug; 294(2):778-83. PubMed ID: 10900260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
